Albanell J - Search Results

1

Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer.

Albanell J, Baselga J. Albanell J, et al. Drugs Today (Barc). 1999 Dec;35(12):931-46. Drugs Today (Barc). 1999. PMID: 12973420

2

Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells.

Molina MA, Codony-Servat J, Albanell J, Rojo F, Arribas J, Baselga J. Molina MA, et al. Among authors: albanell j. Cancer Res. 2001 Jun 15;61(12):4744-9. Cancer Res. 2001. PMID: 11406546

3

Mechanism of action of anti-HER2 monoclonal antibodies.

Baselga J, Albanell J. Baselga J, et al. Among authors: albanell j. Ann Oncol. 2001;12 Suppl 1:S35-41. doi: 10.1093/annonc/12.suppl_1.s35. Ann Oncol. 2001. PMID: 11521720 Free article. Review.

4

Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity.

Ribas A, Albanell J, Bellmunt J, Solé-Calvo LA, Bermejo B, Gallardo E, Vidal R, Vera R, Eres N, Carulla J, Baselga J. Ribas A, et al. Among authors: albanell j. J Clin Oncol. 1996 May;14(5):1573-80. doi: 10.1200/JCO.1996.14.5.1573. J Clin Oncol. 1996. PMID: 8622074 Clinical Trial.

5

Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis.

Bellmunt J, Eres N, Ribas A, Casado S, Albanell J, Baselga J. Bellmunt J, et al. Among authors: albanell j. Cancer Chemother Pharmacol. 1997;40(3):273-6. doi: 10.1007/s002800050658. Cancer Chemother Pharmacol. 1997. PMID: 9219513

6

Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma.

Bellmunt J, Ribas A, Eres N, Albanell J, Almanza C, Bermejo B, Solé LA, Baselga J. Bellmunt J, et al. Among authors: albanell j. Cancer. 1997 Nov 15;80(10):1966-72. doi: 10.1002/(sici)1097-0142(19971115)80:10<1966::aid-cncr14>3.0.co;2-w. Cancer. 1997. PMID: 9366300 Clinical Trial.

7

Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.

Ribas A, Albanell J, Solé-Calvo LA, Gallardo E, Bellmunt J, Vera R, Vidal R, Carulla J, Baselga J. Ribas A, et al. Among authors: albanell j. Cancer. 1998 Mar 1;82(5):878-85. Cancer. 1998. PMID: 9486577 Clinical Trial.

8

Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.

Codony-Servat J, Albanell J, Lopez-Talavera JC, Arribas J, Baselga J. Codony-Servat J, et al. Among authors: albanell j. Cancer Res. 1999 Mar 15;59(6):1196-201. Cancer Res. 1999. PMID: 10096547

9

The ErbB receptors as targets for breast cancer therapy.

Albanell J, Baselga J. Albanell J, et al. J Mammary Gland Biol Neoplasia. 1999 Oct;4(4):337-51. doi: 10.1023/a:1018762216147. J Mammary Gland Biol Neoplasia. 1999. PMID: 10705918 Review.

10

Systemic therapy emergencies.

Albanell J, Baselga J. Albanell J, et al. Semin Oncol. 2000 Jun;27(3):347-61. Semin Oncol. 2000. PMID: 10864222 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters